Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West
- 07:30 - 11:30
- 10/15/2017
- Location: F203 (Annex Hall)
- Type: Joint Session IASLC/CSCO/CAALC
- Track: Immunology and Immunotherapy
- Moderators:C. Bai, Fred R. Hirsch, Tony SK Mok, Yi-Long Wu
-
+
P1.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
P1.06-019 - The Association Between HPV Presence and EGFR Mutations in Asian Patients with NSCLC: A Meta-Analysis
09:30 - 09:30 | Presenter: Hengrui Liang | Author(s): Y. Chen, J. He, Wenhua Liang
- Abstract
Loading...
-
+
P1.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P1.15-011 - Longitudinal Mutation Monitoring in Plasma Without Matching Tumor Tissue by Deep Sequencing in Small Cell Lung Cancer (SCLC)
09:30 - 09:30 | Presenter: André Rosenthal | Author(s): M. Lange, S. Beckert, B. Hinzmann, C. Woestmann, B. Wehnl, M. Schneider, M. Meister, M. Thomas, T. Muley, A. Warth, S. Froehler, J.F. Palma, F.J. Herth
- Abstract
Loading... -
+
P1.15-015 - Prognostic Implication of the FEV1/FVC Ratio in Limited-Stage Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Young-Taek Oh | Author(s): O. Cho, M. Chun, O.K. Noh, J. Heo
- Abstract
Loading...
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-052 - A Clinically-Validated Universal Companion Diagnostic Platform for Cancer Patient Care
09:30 - 09:30 | Presenter: James Sun | Author(s): Y. Li, C. Milbury, J. Skoletsky, C. Burns, W. Yip, J. Luo, N. Dewal, A. Johnson, K. Gowen, J. Tong, Y. He, J. He, J. White, S. Roels, A. Tsuji, J. Truesdell, E. Peters, H. Gilbert, C. Wu, E. Schleifman, C. Barrett, K.S. Thress, S. Jenkins, J. Elvin, G. Otto, D. Lipson, Jeffrey S. Ross, V.A. Miller, P.J. Stephens, M. Doherty, C. Vietz
- Abstract
Loading...
-
+
MA 11 - Emerging Diagnostic/Biomarkers in NSCLC
- 11:00 - 12:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:M.I. Abdul Wahid, Martin Reck
-
+
MA 11.09 - Real World Data of Rebiopsy, Mutation Status, and Its Association with Plasma Genotyping after EGFR TKI Failure in NSCLC
12:00 - 12:05 | Presenter: Min Hee Hong | Author(s): B.C. Ahn, Hye Ryun Kim, S.J. Heo, J.H. Kim, I.Y. Bang, R. Kim, H.W. Jung, H.J. Cho, H. Kim, H. Kim, Byoung Chul Cho
- Abstract
Loading...
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
MA 12.11 - The Alteration of T790M Prevalence Between 19 Deletions and L858R in NSCLC After EGFR-TKIs Therapy, a Meta-Analysis
12:10 - 12:15 | Presenter: Hengrui Liang | Author(s): D. Chen, J. He, W. Liang
- Abstract
Loading...
-
+
OA 08 - Neuroendocrine Carcinoma: Translational
- 11:00 - 12:30
- 10/17/2017
- Location: Room 311 + 312
- Type: Oral
- Track: SCLC/Neuroendocrine Tumors
- Moderators:David S Ettinger, S. Zöchbauer-Müller
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.06 - A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLC
11:55 - 12:05 | Presenter: Jin -Ji Yang | Author(s): Jian Fang, Y. Shu, J. Chang, G. Chen, J. He, W. Li, X. Liu, N. Yang, Caicun Zhou, J. Huang, L. Yang, A.A. Handzel, M.M. Frigault, G. Ahmed, C. Egile, S. Morgan, Yi-Long Wu
- Abstract
Loading...
-
+
MA 15 - Lung Cancer Biology II
- 15:45 - 17:30
- 10/17/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
-
+
MA 17 - Locally Advanced NSCLC
- 15:45 - 17:30
- 10/17/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Oral
- Track: Locally Advanced NSCLC
- Moderators:S. Jheon, Georgios Stamatis
-
+
MA 17.10 - Toxicity Results from the Randomized Phase III NVALT-11 Study of Prophylactic Cranial Irradiation vs. Observation in Stage III NSCLC
16:50 - 16:55 | Presenter: Dirk K De Ruysscher | Author(s): Anne-Marie C. Dingemans, J. Praag, J. Belderbos, C. Tissing-Tan, J. Herder, T. Haitjema, F. Ubbels, F.J. Lagerwaard, J. Stigt, Egbert F Smit, H. Van Tinteren, V. Van Der Noort, H.J. Groen
- Abstract
Loading...